We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fenwal Signs Agreement to Improve Transfusion Safety

By LabMedica International staff writers
Posted on 21 Jul 2009
Print article
Fenwal Inc. (Lake Zurich, IL, USA), a company focused on improving blood collection, separation, safety, and availability signed a five-year exclusive worldwide agreement with Verax Biomedical Inc. (Worcester, MA, USA) to market, sell, and distribute Verax's PanGenera Detection (PGD) technology.

The Verax PGD test, a rapid immunoassay, targets antigens found on the surface of a wide spectrum of common bacteria that are pathogenic to humans in high concentrations. The immunoassay consists of an easy-to-use disposable handheld device and reagents that work together to detect the presence of bacterial contaminants in platelets. The test is performed in less than 30 min. and can be used in hospitals, cancer centers, and other sites of care, as a safeguard immediately prior to transfusion.

An estimated 1 in 2,000 to 3,000 platelet units could contain bacteria, and up to 50 % of bacteria-contaminated platelets can escape detection by conventional culture testing. Bacteria can cause fatal reactions, especially in immune-compromised patients. The Verax PGD immunoassay detects bacteria in leukocyte-reduced apheresis platelets as an adjunct quality-control test following previous bacterial testing.

Verax is developing more PGD technology diagnostic tests to detect bacteria in other blood components, tissues for transplantation, and cell-based therapies. Meanwhile the technology has been cleared by the United States Food and Drug Administration (FDA; Silver Spring, MD, USA) and received the CE marking in Europe.

More than 5 million platelet doses are transfused annually worldwide. Platelets are cells in blood that help blood clot. They are transfused when platelets levels are low--as, for example, a result of illness or the adverse effect of some chemotherapy treatments.

Darrell J. Triulzi, M.D., medical director of the Institute for Transfusion Medicine and the University of Pittsburgh Medical Center's Division of Transfusion Medicine, (UPMC; Pittsburgh, PA, USA) said, "The blood center community has made progress with the implementation of culture-based tests, but these occur at the point of collection when bacteria levels can be too low for detection. A rapid, point-of-care assay, such as the Verax PGD test, takes place just prior to transfusion, which is the best time to detect bacteria levels in platelets and provides a more comprehensive strategy for patient safety."

Related Links:
Fenwal Inc.
Verax Biomedical Inc.
United States Food and Drug Administration
University of Pittsburgh Medical Center


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The AI model accurately classifies pediatric sarcomas using digital pathology images alone (Photo courtesy of Shutterstock)

AI-Driven Analysis of Digital Pathology Images to Improve Pediatric Sarcoma Subtyping

Pediatric sarcomas are rare and diverse tumors that can develop in various types of soft tissue, such as muscle, tendons, fat, blood or lymphatic vessels, nerves, or the tissue surrounding joints.... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.